ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
1-Year Return
2.5%
This Quarter Return
-13.66%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$34.4M
AUM Growth
-$287M
(-89%)
Cap. Flow
-$271M
Cap. Flow
% of AUM
-786.19%
Top 10 Holdings %
Top 10 Hldgs %
87.51%
Holding
68
New
4
Increased
–
Reduced
17
Closed
43
Top Buys
| 1 |
Intelligent Bio Solutions
INBS
|
+$215K |
| 2 |
Sharps Technology
STSS
|
+$110K |
| 3 |
LGMK
LogicMark
LGMK
|
+$107K |
| 4 |
SBFM
Sunshine Biopharma
SBFM
|
+$96.4K |
Top Sells
| 1 |
ADMA Biologics
ADMA
|
+$23.9M |
| 2 |
Vera Therapeutics
VERA
|
+$18.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$15.4M |
| 4 |
Establishment Labs
ESTA
|
+$14.1M |
| 5 |
Edwards Lifesciences
EW
|
+$12.2M |
Sector Composition
| 1 | Healthcare | 99.81% |
| 2 | Consumer Staples | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
ResMed
RMD
$40.9B
| – | – |
-26,000
| Closed | -$5.95M |
|
52
Revolution Medicines
RVMD
$7.68B
| – | – |
-60,000
| Closed | -$2.62M |
|
53
RxSight
RXST
$366M
| – | – |
-285,000
| Closed | -$9.8M |
|
54
Soleno Therapeutics
SLNO
$3.84B
| – | – |
-250,000
| Closed | -$11.2M |
|
55
Syndax Pharmaceuticals
SNDX
$1.47B
| – | – |
-370,000
| Closed | -$4.89M |
|
|
56
Sarepta Therapeutics
SRPT
$1.84B
| – | – |
-127,000
| Closed | -$15.4M |
|
57
Scholar Rock
SRRK
$3.04B
| – | – |
0
| – | – |
|
58
Savara
SVRA
$665M
| – | – |
-1,579,000
| Closed | -$4.85M |
|
59
Terns Pharmaceuticals
TERN
$637M
| – | – |
-475,000
| Closed | -$2.63M |
|
60
TG Therapeutics
TGTX
$5.14B
| – | – |
-95,000
| Closed | -$2.86M |
|
61
Unicycive Therapeutics
UNCY
$77.2M
| – | – |
-147,300
| Closed | -$1.17M |
|
|
62
Vera Therapeutics
VERA
$1.58B
| – | – |
-432,000
| Closed | -$18.3M |
|
63
Glaukos
GKOS
$5.27B
| – | – |
-40,000
| Closed | -$6M |
|
64
ImmunityBio
IBRX
$2.28B
| – | – |
-1,060,000
| Closed | -$2.71M |
|
65
Insmed
INSM
$31B
| – | – |
-132,000
| Closed | -$9.11M |
|
66
Keros Therapeutics
KROS
$628M
| – | – |
-175,000
| Closed | -$2.77M |
|
67
Pulmonx
LUNG
$69.3M
| – | – |
-815,000
| Closed | -$5.53M |
|
68
Lexeo Therapeutics
LXEO
$284M
| – | – |
-405,000
| Closed | -$2.66M |
|